Translational individualised medicine: inflammation and cancer
2024 Activity indicators
- 1 national competitive public project: ISCIII
- 1 RRHH competitive contract
- 44 publications
- IF: 187.10
- Q1 publications: 25 (57%)
- D1 publications: 6 (14%)
- 8 thesis
- Evaluators of public research agencies: 2 PI
- Members of editorial committees: 1 PI
Milestones
- Consolidation of the MITIC-CM Consortium of the Program for R&D activities in Biomedicine of the Community of Madrid (B2022/BMD-7321).
- 8 defended doctoral theses of young clinical researchers with quality indexes and publications in JCR.
- Implementation of the University Chair of Research on the central nervous system (ADAMED).
- Ortega MA, Fraile-Martínez O, García-Montero C, Díaz-Pedrero R, López-González L, Monserrat J, BarrenaBlázquez S, Álvarez-Mon MA, Lahera G, Álvarez-Mon M. Understanding immune system dysfunction and its context in mood disorders: psychoneuroimmunoendocrinology and clinical interventions. Mil Med Res. 2024 Dec 17;11(1):80. doi: 10.1186/s40779-024-00577-w.
- Participation and leadership in the MadrigNight Program "Researchers and citizens: facing together the European challenges".
Bibliometrics
| ARTICLES | ACCUM. IF | MEAN IF | ARTICLES Q1 OR Q2 | % IN Q1 OR Q2 | ARTICLES D1 | % IN D1 | |
|---|---|---|---|---|---|---|---|
| 2020 | 14 | 59.21 | 4.23 | 13 | 93 | 1 | 7 |
| 2021 | 40 | 174.69 | 4.48 | 34 | 85 | 4 | 10 |
| 2022 | 49 | 307.13 | 6.27 | 42 | 86 | 3 | 6 |
| 2023 | 45 | 238.46 | 5.55 | 38 | 84 | 9 | 20 |
| 2024 | 44 | 187.10 | 4.35 | 41 | 93 | 6 | 14 |
| 192 | 966.59 | 4.98 | 168 | 88 | 23 | 12 |
